An accelerating effect of methyl-deficient diet (MDD) on hepatocarcinogenesis and methylation pattern of nuclear protein(s) by S-adenosylmethionine: protein arginine N-methyltransferase (protein methylase I, PM-I) have been studied with 3'-methyl-4-dimethyl-aminoazobenzene(MeDAB)-treated rats. The MDD+MeDAB-fed group produced typical cancer cells in the liver almost two weeks earlier than the control synthetic diet (CSD)+MeDAB-fed group. Protein methylase I (PM-I) activity in the livers of MDD alone fed rats began to increase at around 2 weeks after MDD-feeding, reaching a peak at 4 weeks and declining thereafter. When nuclei isolated either from normal livers or from cholangiocarcinoma cells were incubated with PM-I preparation from normal liver, 16 and 23-kDa nuclear proteins were the major methylated proteins, regardless of the source of the nuclei. However, when the above mentioned nuclei were incubated with PM-I preparations either from MDD alone fed livers or MDD+ MeDAB-induced cholangiocarcinoma cells, the methylation of 23-kDa protein was not detected. The result suggests that there is a hitherto-unknown PM-I specific to 23 kDa nuclear protein which was lost during methyl deficient diet feeding and hepa- 
Introduction
Protein methylation is one of the posttranslational modification reactions which modulate the function of proteins. Among many protein-specific methylation reactions, enzymatic methylation of protein-arginine residues has been suggested to be involved closely in cellular growth and differentiation. These contentions are based on the following evidences. First, the enzyme S-adenosylmethionine: protein-arginine N-methyltransferase (protein methylase I; PM-I; EC 2.1.1.23) which is responsible for the methylation increased significantly in fast growing tissues (Tidwell et al., 1968; Lee and Paik, 1972; Paik and Kim, 1980; Wainfan et al., 1988) . Secondly, many highly specialized chromosomal proteins are found to be arginine-methylated in vivo (Reporter and Corbin, 1971; Karn et al ., 1977) . Thirdly, an increase of PM-I activity precedes the synthesis of DNA in synchronized cell cultures (Paik and Kim, 1980; Choi, 1989 ). An evidence also indicated that protein-arginine N-methylation might play a role in carcinogenesis (Yoon, 1994; Duerre et al., 1994) .
Hepatocarcinogenesis has been found to be accelerated in methyl-deficient experimental animals and this effect of methyl-deficiency is attributed to insufficiency of methylation of newly formed DNA (Doerfler, 1983; Hoffman, 1985) and/or chromosomal proteins (Duerre, 1988) . Obviously, chromosomal protein methylation includes arginine-methylation of non-histone chromosomal proteins. In order to elucidate biochemical function and significance of protein-arginine N-methylation, it appears to be imperative to identify protein species methylated under specific biological situations. Najbauer and Aswad (1990) found over 90% of the endogenous proteins were arginine N-methylated in pheochromocytoma cells (PC 12 cell line) which were initially hypomethylated with a methylation inhibitor, followed by incubation with A d o [m e t h y l-3 H]Met. However, they did not attempt to identify the proteins involved. We recently identified a number of methyl acceptor proteins (68, 45, 38, 23 and 16 kDa) in human placental nuclear fraction methylated by PM-I (Paik et al., 1991; Choi et al., 1993) . Furthermore, the extents of methylation of 16-kDa and 23 kDa proteins were very different in opposing manner during hepatic regeneration of rat. It was suggested that methylation of the 16 kDa protein might be involved in cellular growth whereas that of the 23 kDa in cellular differentiation .
In the present study, we fed rats with methyl deficient diet (MDD), and confirmed that the induction of cholangiocarcinoma by 3'-methyl-4-dimethylaminoazobenzene (MeDAB) was accelerated in these animals. During the induction, however, the 23-kDa protein methylation was lost. The amino acid sequence analysis of N-terminal 20 amino acids showed 94.7% sequence homology with human chorionic somatomammotropin.
Materials and Methods

Materials
S -A d e n o s y l -L-[m e t h y l-1 4 C]methionine (specific activity, 49 mCi/mmol) and S-adenosyl-L-[m e t h y l-
3 H ] m e t h i o n i n e (specific activity, 73 Ci/mmol) were purchased from Amersham International. Acrylamide, glycine, hydroxyapatite, and PVDF protein sequence membrane were obtained from Bio-Rad Laboratories, and DEAE-Sephacel from Pharmacia. Histone type II-AS (a mixture of various subtypes of calf thymus histone), histone H2A, histone H3, dithiothreitol, phenylmethylsulfonyl fluoride (PMSF), trizma base and 2,5-diphenyloxazole were from Sigma Chemical Co. MDD and control synthetic diet (CSD) were prepared by Harlan Teklad, Wisconsin, and 3'-4-dimethylaminoazobenzene from Tokyo Whasei Co., Japan. The rest of the reagents were obtained from various commercial sources and of the highest purity available. 
Experimental animals
Sprague-Dawley rats, weighing approximately 150 g, were fed for 2 weeks with normal diet before the start of experiments. After acclimatization, the animals were divided into MDD alone, CSD+0.07% MeDAB, and MDD+0.07% MeDAB groups, and the animals were fed with the diets for 12weeks. MeDAB was dissolved in corn oil. The composition of the diets are listed in Table 1 .
Enzyme assay
Protein methylase I activity was assayed according to the method of Paik and Kim (1980) . Incubation mixture containing 100 μl of 0.2 M phosphate buffer (pH 7.6), 50 μl of histone II-AS (40 mg/ml) and 50 μl of enzyme preparation was preincubated at 37˚C for 3 min, followed by the addition of 20 μl of Ado[m e t h y l-1 4 C]Met (2.5 nmol, 0.125 μCi). Incubation was carried out for 30 min at 37˚C. The enzyme preparation boiled for 5 min served as a blank for the enzyme. The reaction was terminated by adding 4 ml of 15% trichloroacetic acid to the mixture. Unreacted Ado[m e t h y l- C]Met, nucleic acid, phospholipid and the product formed by contaminating protein methylase II (S-adenosyl-methionine: protein carboxyl O-methyltransferase; EC 2.1.1.24) were removed, and the final precipitate was dissolved in 10 ml of liquid scintillation fluid for radioactivity counting.
Protein concentration was estimated by the method of Bradford (1976) , using bovine serum albumin as the standard.
Partial purification of protein methylase I
All the procedures were carried out at 4˚C. Ten g of liver from MDD+MeDAB fed rats or normal rats was homogenized in 40 ml of buffer A containing 0.5 mM EDTA, 0.5 mM PMSF, 1 mM dithiothreitol, 5 mM NH 4 Cl, 10% glycerol, 5 mM phosphate buffer (pH 7.4) by polytron Brinkman homogenizer for 10 s five times. The homogenate was centrifuged at 39,000 g for 30 min and finely powdered (NH 4 ) 2 SO 4 was added to the supernatant at 58% saturation. The mixture was left in ice-bath for 30 min and then centrifuged at 39,000 g for 30 min. The precipitate was dissolved in 7 ml of buffer A (pH 8.0), and (NH 4 ) 2 SO 4 was added at 55% saturation. The enzyme preparation was dialyzed against buffer A (pH 8.0), the volume was made up to 50 ml, and the sample was loaded onto DEAE-Sephacel chromatography column (1.4 4.5 cm; packing volume, 7 ml) which had been equilibrated with buffer A. The column was washed with 50 mM buffer A (pH 8.0) until no 280 nm absorbing material was detected. The column was eluted with a linear gradient formed by 35 ml each of buffer A (pH 8.0) containing 0 and 500 mM NaCl. Fraction volume was 50 drops (2.5 ml). The enzyme activity was detected in fractions 7 to 14, and the contents of fraction 8 through 12 were pooled (Figure Table 1 5 ml 5 ml MeDAB 0.7 g 0.7 g 1). The pooled sample was made to 60% (NH 4 ) 2 S O 4 , dialyzed against buffer A (pH 8.0), and the volume was made to 30 ml. The sample was subsequently loaded onto hydroxyapatite column (0.7 2.5 cm; packing volume, 1 ml) which had been equilibrated with buffer A.
The column was eluted with a linear gradient formed by 10 ml each of buffer A containing 5 mM and 300 mM phosphate. Fraction volume was 20 drops (1 ml), and the enzyme activity was detected in fractions 5 through 10 ( Figure 2 ). The samples of fraction 6 and 7 were pooled and were used throughout this experiment. Protein concentration was 2.6 mg/ml.
Preparation of liver nuclear fraction
Rat liver nuclear fraction was prepared according to the method of Kay and Johnson (1977) . Approximately 30 g of rat liver was homogenized in 3 times volume of 10 mM Tris-HCl buffer (pH 7.4) containing 0.32 M sucrose, 3 mM MgCl 2 , 0.5 mM PMSF, and the homogenate was centrifuged at 700 g for 10 min. The pellet obtained was resuspended in the above sucrose solution and was centrifuged again at 700 g for 10 min. The crude nuclear fraction thus obtained was suspended in 2.4 M sucrose, 1 mM MgCl 2 , 0.5 mM PMSF, 10 mM Tris buffer (pH 7.4), and the suspension was centrifuged at 50,000 g for 60 min. The precipitate was suspended in 0.25 M sucrose, 1 mM MgCl 2 , 0.5 mM PMSF, 10 mM Tris buffer (pH 7.4), and the suspension was finally centrifuged at 700 g for 10 min to obtain a nuclear fraction.
SDS-PAGE and autofluorography of methyl-3 Hlabeled proteins
In order to identify m e t h y l-3 H-labeled proteins m e t h ylated by PM-I of normal and MDD+MeDAB-treated r a t livers, 200 μl of total incubation mixture containing PM-I, substrate proteins (liver nuclear fraction), Ado[m e t h y l-3 H]Met (0.125 nmol, 20 μCi) and 15 μmol of phosphate buffer (pH 7.8) was incubated at 37˚C for 1 h. Precipitate formed by adding enough amount of absolute ethanol was collected by centrifugation, the precipitate air-dried, and the dried sample dissolved in 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.002% bromophenol blue, 62 mM Tris buffer (pH 6.8). The sample was electrophoresed (SDS-PAGE), followed by autofluorography according to the method of Thomas and Kornberg (1977) modified from the method of Laemmli (1970) . Electrophoresis was carried out at 40 mA for 12 h, the gels were stained by 0.1% Coomassie brilliant blue, and were destained with 50% methanol, 10% acetic acid. For autofluorography, the destained gels were soaked in dimethylsulfoxide containing 20% 2,5-diphenyloxazole for 1 h. After drying, the gels were exposed to Fuji medical X-ray films for 2-7 days at -70˚C.
Isolation of nuclear membrane
Preparation of liver nuclear membrane was carried out at 4˚C by the method of Kaufmann et al. (1982) . The purified nuclei were suspended at 3-5 10 8 nuclei/ml in Figure 1 DEAE-Sephacel chromatography of protein methylase I of MDD+MeDAB treated rat liver. Ammonium sulfate treated preparation was applied to DEAE-Sephacel column(1.4 x 4.5 cm; packing volume, 7 ml) equilibrated previously with 5 mM phosphate buffer(pH 8.0) containing 1 mM DTT, 0.5 mM EDTA, 0.5 mM PMSF, 5 mM NH 4 Cl, 10% glycerol. Flow rate was 24 ml/h and 2.5 ml(50 drops) of eluate was collected. represents A280 nm and for enzyme activity. An assay was performed as described under "Materials and Methods". Hydroxyapatite chromatography of protein methylase I of MDD+MeDAB treated rat liver. DEAE-Sephacel chromatography fractions were applied onto hydroxyapatite column(0.7 x 2.5 cm; packing volume, 1 ml) equilibrated previously with 5 mM phosphate buffer(pH 8.0) containing 1 mM DTT, 0.5 mM EDTA, 0.5 mM PMSF, 5 mM NH 4 Cl, 10% glycerol. Flow rate was 12 ml/h and 1 ml(20 drops) of eluate was collected.
represents A280 nm and for enzyme activity. An assay was performed as described under "Materials and Methods". 0.25 M sucrose, 5 mM MgCl 2 , 50 mM Tris (pH 7.4 at 4˚C) (called STM in the following), and the suspension was treated with DNAse (250 μg/ml) and RNAse I (250 μg/ml) at 4˚C for 1 h. The suspension was then centrifuged at 800 g for 10 min. The pellet was suspended in 10 mM Tris buffer (pH 7.4), 0.2 mM MgSO 4 followed by drop-wise addition of the buffer containing 2 M NaCl, and 2-mercaptoethanol to the suspension to 1% final concentration while stirring. The mixture was incubated at 4˚C for 15 min, and the precipitate was collected by centrifugation at 1,600 g for 30 min. The procedure was repeated once more with the above buffer which did not contain 2-mercaptoethanol. Finally, the precipitate was dissolved in 0.25 M sucrose, 5 mM MgCl 2 -50 mM Tris buffer (pH 7.4).
Purification of 23-kDa protein
The rat liver nuclear membrane (8.5 mg) isolated above was methylated by purified PM-I in the presence of
A d o [m e t h y l-
3 H]Met, and m e t h y l-3 H-labeled 23-kDa protein was obtained by a preparatory gel elctrophoresis (Prep-Cell, Bio-Rad Model 491) (Laemmli, 1970) .
Thus, m e t h y l-3 H-labeled nuclear envelope (0.85 mg) was suspended in the sample buffer containing 2.5% glycerol, 0.5% SDS, 0.005% bromophenol blue, the sample was loaded for SDS-polyacrylamide gel, and preparatory electrophoresis was performed at 12 watt for 6 h. Two and half ml of each fractions were collected at the rate of 1 ml/min. With the use of SDS-PAGE and fluorography, the 23-kDa protein was identified a n d fractions containing 23-kDa protein were pooled. The pooled sample was concentrated by Speed-Vac and Centricon 10, electrophoresed, and transferred to PVDF membrane by the use of Wet-Blotter (Sigma). For transblotting, Towbin buffer was employed at 30 volts for 12 h. PVDF membrane containing the 23-kDa protein was sent to Korean Science Foundation for amino acid sequence analysis.
Results
Comparison of carcinogenesis of CSD+MeDAB and MDD+MeDAB rats
In order to study the effect of methyl deficient state on carcinogenesis, animals were fed CSD plus MeDAB and MDD plus MeDAB diets. During hepatocarcinogenesis, oval cell proliferation, hyperplastic nodule, cholangiofibrosis and cholangiocarcinoma were examined. As shown in Table 2 , CSD+MeDAB treatment resulted in proliferation of oval cells at 2 weeks, and proliferation increased greatly at 8 weeks. Cholagiocarcinoma appeared on 10 weeks of treatment. In contrast to the above, MDD+MeDAB treated rats showed cholangiocarcinoma 2-4 weeks earlier than the CSD+MeDAB group, and steatosis (fatty change) much earlier than CSD+MeDAB-treated rats (Table 3 and Figure 3 -5). It is also noted that the change occurred much more widely.
Change of protein methylase I activity by MDD
As shown in Table 4 , protein methylase I activity began to increase at about 2 weeks of MDD-feeding, reaching about 50% increase at 4 weeks and declining thereafter. However, considerably high enzyme activity was maintained even after 8 weeks of the experiment.
Purification of protein methylase I
Protein methylase I has been partially purified from the livers of CSD-fed, MDD-fed and MDD+MeDAB-fed rats up to DEAE-Sephacel and hydroxyapatite column chromatography. Although there was not much difference in the procedures among these livers, the purification procedure of the liver of MDD+MeDAB treated rat is presented in Figures 1, 2 and Table 5 . Thus, the enzyme purified from this source was routinely employed in the following experiment. As shown in Table 5 , the enzyme was purified approximately 27-fold with a yield of 30% from MDD+MeDAB rat liver.
Methylation of 16-kDa and 23-kDa proteins
In order to investigate which nuclear proteins are methylated during accelerated induction of cholangiocarcinoma by methyl-deficient state, the PM-Is purified from both normal and MDD+MeDAB treated rat livers were incubated with nuclei isolated from normal and MDD+MeDAB livers in the presence of Ado[m e t h y l-3 H]Met, and methyl-3 H-labeled proteins were identified by SDS-PAGE and autofluorography (Figures 6-7) . In Figure 6 , nuclei (here, used as substrate for methylation) were isolated from CSD+MeDAB treated rat liver while PM-I was from normal liver. The numbers 2, 4, 6, 8, 10, 12 and 14 represent 2, 4, 6, 8, 10 , 12 and 14 weeks of treatment. It is apparent that methylation of 16-and 23-kDa proteins are very prominent and that the longer the treatment the stronger the intensity of methylation. On the other hand, as seen in Figure 7 , when both PM-I and nuclei were isolated from CSD+MeDAB treated rat liver, the methylation of 23-kDa protein is not present although the methylation of 16-kDa protein remained the same as in Figure 6 . Since nuclei used in both Figures 6 and 7 were isolated from the same source and PM-I came from differently treated animals, the loss of 23-kDa methylation is due to the fact that PM-I responsible for methylation of 23-kDa protein was lost in MeDAB-treatment.
Sequence of N-terminal 20 amino acid of 23 kDa protein
The 23-kDa protein was purified by Prep-Cell (Bio-Rad) after methylating isolated nuclei with purified PM-I of normal rat liver. The sequence of 20 terminal amino acids were 1 G l y -V a l -P r o -L e u -5 X-Arg-Leu-Phe-Asp-
From the search of Data-Bank, this sequence was found to have 94.7% homology with human chorionic somatomammotropin (Table 6 ). Although the identity of the fifth amino acid is not known, this is most likely Nmethylated arginine.
Discussion
When a hepatocarcinogen L-ethionine was given to partially hepatectomized rats, methylation of histone and non-histone chromosomal proteins was found to be greatly reduced, although their synthesis was not affected Table 6 . N-terminal amino acid sequence of 23-kDa nuclear methyl acceptor protein. (Cox and Tuck, 1981; Tuck and Cox, 1982) . The results suggest that methylation of these proteins are involved in induction of cancer. Furthermore, the methylation of non-histone chromosomal proteins was much more reduced than histone on L-ethionine administration (Cox and Tuck, 1981; Tuck and Cox, 1982) . It is well known that histones which constitute nucleosome structure is lysine N-methylated whereas non-histone chromosomal proteins are arginine N-methylated (Duerre and Onisk, 1985; Duerre et al , 1990) , suggesting that methylation of non-histone chromosomal proteins observed during carcinogenesis is arginine Nmethylation. Yoon (1994) recently reported that arginine Nmethylation of 23-kDa nuclear protein might be involved in the induction of cancer by MeDAB. The present results confirmed the observation of Yoon that 23-kDa protein arginine methylation might indeed be involved in the accelerating effect of MDD in cancer induction. When PM-I of normal liver was incubated with nuclei of normal liver with Ado[methyl-3 H]Met, 16-and 23-kDa proteins were heavily methylated ( Figure  6 ). The degree of methylation seemed to increase as the tumorigenesis progressed. On the other hand, when PM-I of cancer tissue was reacted with nuclei of both normal or cancerous tissues, the methylation of 23-kDa protein was not visible, although the methylation of 16-kDa remained undiminished. This result shows a
41
Non-histone nuclear methyl acceptor protein close relationship between the induction of cancer and methylation of 23-kDa protein, and agrees well with the result of Yoon (1994) .
The loss of 23-kDa protein methylation (Figures 6-7 ) is due to the loss of 23 kDa-protein specific protein methylase I. There exist a few different subtypes of protein methylase I . For example, myelin basic protein specific PM-I methylates myelin basic protein only, and heterogenous nuclear ribonucleoprotein particle protein A1 (protein A1)-specific PM-I methylates both histones and protein A1 (Rajpurohit et a l., 1994) . These two subtypes of protein methylase I have been distinguished in their molecular weights, affinities for protein substrates, and immunological recognition. It is, therefore, suggested that PM-I not only recognizes potential methylatable arginine residues, but also protein structure. As shown in Figures 6 and 7 , evidence indicates a presence of 23 kDa-protein s p e c i f i c PM-I which is lost during carcinogenesis.
We have earlier suggested that methylation of 16-and 23-kDa nuclear proteins are involved in cellular growth and differentiation. During hepatic regeneration of rats, changing patterns of 16-and 23-kDa protein methylation were quite different in opposing manner: While 16-kDa protein methylation increased as the growth progressed, 23-kDa protein methylation was not seen first and reappeared as the growth slowed down . Involvement of 16-and 23-kDa nuclear protein methylation in cellular growth and differentiation was also observed in human placenta (Paik et al., 1991; Choi et al., 1992) . While methylation of both 16-and 23-kDa proteins occurred in human placenta during the early stage of pregnancy when DNA synthesis was high, only 23-kDa protein methylation was observed in the later stage placenta when only protein synthesis occurred in the differentiated state. Thus, the loss of 23-kDa protein methylation in MDD+MeDAB treated rats could mostly be due to the loss of 23-kDa protein-specific protein methylase I. Since it has been well known that methyl deficiency accelerates cellular growth (Abanobi et al. , 1982) , the enzymatic methylation of both 16-and 23-kDa nuclear proteins might be heavily involved in carcinogenesis.
The sequence of N-terminal 20 amino acids of 23-kDa nuclear protein purified from nuclear membrane had 94.7% homology with human placental somatomammotropin (precursors A and B), suggesting the identity of 23-kDa protein with human chorionic somatom a m m o t r opin. However, a few unsettling questions exist. First, this hormone is produced by placenta and presents in the cytosol, whereas 23-kDa protein was isolated from nuclei. Secondary, the 23-kDa protein methylation varied during hepatic regeneration. Since the biochemical function of somatomammotropin is not well understood, the biological significance of this protein (the 23-kDa protein and/or somatomammotropin) is not clear at present.
